• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home AI Roundup

FDA clears Medtronic stealth AXiS AI-Robotic spine system

byDeepti Shroff
February 18, 2026
in AI Roundup, Orthopedic Surgery
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. The Stealth AXiS™ system has received regulatory clearance as the first platform to natively unify AI-driven planning and robotic execution for spinal procedures.

2. Real-time segmental tracking technology allows for the visualization of anatomic motion during surgery, reducing the need for repeated intraoperative CT imaging.

The FDA recently issued a landmark clearance for the Stealth AXiS™ system, representing a major consolidation of digital tools in the neurosurgical suite. Currently, navigation systems are utilized in roughly 70% of spine procedures in the United States, yet many require fragmented software toggling that can disrupt operative momentum and increase cognitive load. This integrated technology introduces segmental tracking capabilities, allowing for the real-time visualization of anatomic motion without the need for repeated intraoperative imaging sequences. The platform serves as a cornerstone of a broader digital ecosystem that connects preoperative data with real-time robotic execution in a single workflow. By utilizing AI-driven modeling, the system can refine screw trajectories based on patient-specific bone density and morphometry with exceptionally high precision. This streamlined approach aims to minimize the variability often seen in complex multi-level fusions by automating several manual registration steps. For surgical teams, the consolidated footprint is designed to facilitate adoption in both traditional hospital settings and ambulatory surgery centers. Predictive modeling helps select optimal hardware sizes, potentially reducing the “trial and error” aspect of instrumentation. Improved accuracy in screw placement may also lead to lower revision rates, which historically stem from malpositioning in complex anatomy. The system’s ability to maintain registration during patient movement helps ensure that the robotic guidance remains accurate throughout the entirety of the case. Furthermore, the reduction in required intraoperative scans could significantly decrease radiation exposure for both the patient and the surgical staff. While the technical advantages are clear, the high initial capital investment remains a critical factor for institutional adoption. It is currently unclear if these workflow efficiencies will lead to a measurable reduction in long-term adjacent segment disease. At present, the system provides a sophisticated digital cockpit that enhances the surgeon’s ability to execute complex plans. This advancement marks a significant milestone in the move toward fully autonomous robotic assistance in spine care.

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

RELATED REPORTS

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

NVIDIA GTC 2026 turns healthcare AI into a pop-culture phenomenon

The Scan by 2 Minute Medicine®: Susie Wiles breast cancer diagnosis drives national screening surge, Jensen Huang’s GTC keynote turns healthcare AI into a pop-culture phenomenon, landmark ACSM guidelines simplify resistance training for longevity, and consumer alert issued for high-pressure cosmetic surgery chains

Tags: artificial intelligenceFDAmedtronicroboticsspinal fusionspine surgery
Previous Post

Sodium-glucose cotransporter 2 inhibitors may improve left ventricular diastolic function in hypertrophic cardiomyopathy

Next Post

Two plasma-based biomarkers may accurately predict positive CT head scans in traumatic brain injury

RelatedReports

2 Minute Medicine: Pharma Roundup: Price Hikes, Breakthrough Approvals, Legal Showdowns, Biotech Expansion, and Europe’s Pricing Debate [May 12nd, 2025]
Endocrinology

2 Minute Medicine: Pharma Roundup – Pfizer’s Talzenna delays prostate cancer progression, apixaban lowers VTE bleeding risk, Lilly’s retatrutide hits Phase III metabolic targets, and FDA warns Novo Nordisk over safety reporting violations [March 2026]

March 30, 2026
Record-based algorithm may improve lung cancer screening follow-up
All Specialties

NVIDIA GTC 2026 turns healthcare AI into a pop-culture phenomenon

March 26, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Artificial Intelligence

The Scan by 2 Minute Medicine®: Susie Wiles breast cancer diagnosis drives national screening surge, Jensen Huang’s GTC keynote turns healthcare AI into a pop-culture phenomenon, landmark ACSM guidelines simplify resistance training for longevity, and consumer alert issued for high-pressure cosmetic surgery chains

March 25, 2026
Variation noted across pre- and post-marketing studies for FDA approved devices
Hematology

FDA grants priority review for iberdomide-based myeloma regimen

March 6, 2026
Next Post
Brain lesions on MRI linked with subsequent increased stroke risk

Two plasma-based biomarkers may accurately predict positive CT head scans in traumatic brain injury

2MM: AI Roundup- AI Cancer Test, Smarter Hospitals, Faster Drug Discovery, and Mental Health Tech [May 2nd, 2025]

Artificial intelligence designed drugs Hit 90% Phase I success rate in trials

Mutation linked with decrease in cutaneous diffuse large B-cell lymphoma

Penpulimab and lenalidomide in combination with standard of care chemoimmunotherapy demonstrates promising safety and efficacy in diffuse large B-cell lymphoma

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Placental abruption during pregnancy is not associated with increased risk of cardiovascular mortality in children
  • Pfizer’s Talzenna combo significantly delays prostate cancer progression
  • Bottom-vented bottles may not reduce gastrointestinal discomfort in infants
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

The Classics in Medicine Paperback Released!

Over the past 30 years, the transition from print to digital media has contributed to an exponential increase in medical literature. In response, 2 Minute Medicine presents 160+ authoritative, physician-written summaries of the most cited landmark trials in medicine.

amazon-logo_blackGet-it-on-iBooks-badge

Click anywhere to close this announcement

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • RVU Search
    • NPI Registry Lookup
  • Pharma
  • AI News
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.